AAPL324.53-0.61 (-0.19%) ▼|ABBV258.72-1.27 (-0.49%) ▼|ABT112.09+3.16 (+2.90%) ▲|ACN186.16-1.93 (-1.03%) ▼|ADBE282.68-3.41 (-1.19%) ▼|AMAT437.13-4.73 (-1.07%) ▼|AMD457.95-1.66 (-0.36%) ▼|AMGN437.01-1.11 (-0.25%) ▼|AMT174.30-1.72 (-0.98%) ▼|AMZN255.10+0.18 (+0.07%) ▲|AVGO369.77+0.09 (+0.02%) ▲|AXP329.95+5.76 (+1.78%) ▲|BA210.00+4.34 (+2.11%) ▲|BAC63.18+1.19 (+1.91%) ▲|BKNG198.67+2.98 (+1.52%) ▲|BLK1,123.43-4.67 (-0.41%) ▼|BMY67.06+0.14 (+0.21%) ▲|BNY161.84+1.33 (+0.83%) ▲|BRK-B507.73+5.40 (+1.08%) ▲|C134.93+2.39 (+1.80%) ▲|CAT785.34+6.18 (+0.79%) ▲|CL90.45+0.82 (+0.91%) ▲|CMCSA27.06+0.76 (+2.89%) ▲|COF218.64+7.30 (+3.45%) ▲|COP136.28+0.09 (+0.07%) ▲|COST934.82-5.14 (-0.55%) ▼|CRM255.33-2.79 (-1.08%) ▼|CSCO109.01-0.73 (-0.67%) ▼|CVS98.41+0.81 (+0.83%) ▲|CVX211.71+0.66 (+0.31%) ▲|DE686.10+10.02 (+1.48%) ▲|DHR210.09+3.16 (+1.52%) ▲|DIS108.68+2.46 (+2.31%) ▲|DUK120.34-0.05 (-0.04%) ▼|EMR149.61+1.98 (+1.34%) ▲|FDX322.30-2.58 (-0.79%) ▼|GD363.41-6.01 (-1.63%) ▼|GE332.17+1.08 (+0.33%) ▲|GEV901.08+2.55 (+0.28%) ▲|GILD150.10+0.18 (+0.12%) ▲|GM85.09-0.54 (-0.63%) ▼|GOOG333.66+1.63 (+0.49%) ▲|GOOGL337.29+2.27 (+0.68%) ▲|GS1,007.58+5.02 (+0.50%) ▲|HD320.31+0.54 (+0.17%) ▲|HON208.39-1.59 (-0.76%) ▼|IBM230.57-0.83 (-0.36%) ▼|INTC89.54+0.57 (+0.64%) ▲|INTU343.17-1.77 (-0.51%) ▼|ISRG380.16+10.91 (+2.95%) ▲|JNJ274.41+3.22 (+1.19%) ▲|JPM358.82+3.87 (+1.09%) ▲|KO88.78+0.78 (+0.89%) ▲|LIN488.69+1.93 (+0.40%) ▲|LLY1,174.01+14.01 (+1.21%) ▲|LMT533.01-11.50 (-2.11%) ▼|LOW201.48+1.43 (+0.71%) ▲|LRCX287.10-3.10 (-1.07%) ▼|MA589.42+8.32 (+1.43%) ▲|MCD262.52+1.41 (+0.54%) ▲|MDLZ62.37+0.76 (+1.23%) ▲|MDT94.26+2.22 (+2.41%) ▲|META595.84+17.30 (+2.99%) ▲|MMM169.96-0.28 (-0.17%) ▼|MO69.49-0.08 (-0.12%) ▼|MRK150.63+0.77 (+0.51%) ▲|MS213.63+2.59 (+1.23%) ▲|MSFT497.62-3.40 (-0.68%) ▼|MU940.77+7.33 (+0.78%) ▲|NEE82.77-0.16 (-0.19%) ▼|NFLX82.68+1.87 (+2.31%) ▲|NKE38.48+0.36 (+0.94%) ▲|NOW138.12-4.78 (-3.35%) ▼|NVDA226.23+8.79 (+4.04%) ▲|ORCL145.44+4.12 (+2.92%) ▲|PEP141.48+1.69 (+1.21%) ▲|PFE28.86+0.31 (+1.07%) ▲|PG147.58+1.37 (+0.94%) ▲|PLTR170.04-9.88 (-5.49%) ▼|PM188.16+1.01 (+0.54%) ▲|QCOM169.42+2.81 (+1.69%) ▲|RTX204.58-0.61 (-0.30%) ▼|SBUX105.70-0.45 (-0.42%) ▼|SCHW108.66+0.37 (+0.34%) ▲|SO87.42-0.70 (-0.79%) ▼|SPG210.65-1.24 (-0.58%) ▼|T26.21+0.20 (+0.75%) ▲|TMO607.30+6.80 (+1.13%) ▲|TMUS187.48+5.32 (+2.92%) ▲|TSLA355.30-0.79 (-0.22%) ▼|TXN252.88-0.46 (-0.18%) ▼|UBER76.57+1.32 (+1.75%) ▲|UNH398.66+2.24 (+0.56%) ▲|UNP289.84-0.74 (-0.25%) ▼|UPS103.58+0.93 (+0.90%) ▲|USB61.78+0.58 (+0.94%) ▲|V376.75+4.01 (+1.07%) ▲|VZ50.43+0.11 (+0.22%) ▲|WFC88.09+1.04 (+1.19%) ▲|WMT105.61-0.31 (-0.29%) ▼|XOM164.01-0.55 (-0.33%) ▼|AAPL324.53-0.61 (-0.19%) ▼|ABBV258.72-1.27 (-0.49%) ▼|ABT112.09+3.16 (+2.90%) ▲|ACN186.16-1.93 (-1.03%) ▼|ADBE282.68-3.41 (-1.19%) ▼|AMAT437.13-4.73 (-1.07%) ▼|AMD457.95-1.66 (-0.36%) ▼|AMGN437.01-1.11 (-0.25%) ▼|AMT174.30-1.72 (-0.98%) ▼|AMZN255.10+0.18 (+0.07%) ▲|AVGO369.77+0.09 (+0.02%) ▲|AXP329.95+5.76 (+1.78%) ▲|BA210.00+4.34 (+2.11%) ▲|BAC63.18+1.19 (+1.91%) ▲|BKNG198.67+2.98 (+1.52%) ▲|BLK1,123.43-4.67 (-0.41%) ▼|BMY67.06+0.14 (+0.21%) ▲|BNY161.84+1.33 (+0.83%) ▲|BRK-B507.73+5.40 (+1.08%) ▲|C134.93+2.39 (+1.80%) ▲|CAT785.34+6.18 (+0.79%) ▲|CL90.45+0.82 (+0.91%) ▲|CMCSA27.06+0.76 (+2.89%) ▲|COF218.64+7.30 (+3.45%) ▲|COP136.28+0.09 (+0.07%) ▲|COST934.82-5.14 (-0.55%) ▼|CRM255.33-2.79 (-1.08%) ▼|CSCO109.01-0.73 (-0.67%) ▼|CVS98.41+0.81 (+0.83%) ▲|CVX211.71+0.66 (+0.31%) ▲|DE686.10+10.02 (+1.48%) ▲|DHR210.09+3.16 (+1.52%) ▲|DIS108.68+2.46 (+2.31%) ▲|DUK120.34-0.05 (-0.04%) ▼|EMR149.61+1.98 (+1.34%) ▲|FDX322.30-2.58 (-0.79%) ▼|GD363.41-6.01 (-1.63%) ▼|GE332.17+1.08 (+0.33%) ▲|GEV901.08+2.55 (+0.28%) ▲|GILD150.10+0.18 (+0.12%) ▲|GM85.09-0.54 (-0.63%) ▼|GOOG333.66+1.63 (+0.49%) ▲|GOOGL337.29+2.27 (+0.68%) ▲|GS1,007.58+5.02 (+0.50%) ▲|HD320.31+0.54 (+0.17%) ▲|HON208.39-1.59 (-0.76%) ▼|IBM230.57-0.83 (-0.36%) ▼|INTC89.54+0.57 (+0.64%) ▲|INTU343.17-1.77 (-0.51%) ▼|ISRG380.16+10.91 (+2.95%) ▲|JNJ274.41+3.22 (+1.19%) ▲|JPM358.82+3.87 (+1.09%) ▲|KO88.78+0.78 (+0.89%) ▲|LIN488.69+1.93 (+0.40%) ▲|LLY1,174.01+14.01 (+1.21%) ▲|LMT533.01-11.50 (-2.11%) ▼|LOW201.48+1.43 (+0.71%) ▲|LRCX287.10-3.10 (-1.07%) ▼|MA589.42+8.32 (+1.43%) ▲|MCD262.52+1.41 (+0.54%) ▲|MDLZ62.37+0.76 (+1.23%) ▲|MDT94.26+2.22 (+2.41%) ▲|META595.84+17.30 (+2.99%) ▲|MMM169.96-0.28 (-0.17%) ▼|MO69.49-0.08 (-0.12%) ▼|MRK150.63+0.77 (+0.51%) ▲|MS213.63+2.59 (+1.23%) ▲|MSFT497.62-3.40 (-0.68%) ▼|MU940.77+7.33 (+0.78%) ▲|NEE82.77-0.16 (-0.19%) ▼|NFLX82.68+1.87 (+2.31%) ▲|NKE38.48+0.36 (+0.94%) ▲|NOW138.12-4.78 (-3.35%) ▼|NVDA226.23+8.79 (+4.04%) ▲|ORCL145.44+4.12 (+2.92%) ▲|PEP141.48+1.69 (+1.21%) ▲|PFE28.86+0.31 (+1.07%) ▲|PG147.58+1.37 (+0.94%) ▲|PLTR170.04-9.88 (-5.49%) ▼|PM188.16+1.01 (+0.54%) ▲|QCOM169.42+2.81 (+1.69%) ▲|RTX204.58-0.61 (-0.30%) ▼|SBUX105.70-0.45 (-0.42%) ▼|SCHW108.66+0.37 (+0.34%) ▲|SO87.42-0.70 (-0.79%) ▼|SPG210.65-1.24 (-0.58%) ▼|T26.21+0.20 (+0.75%) ▲|TMO607.30+6.80 (+1.13%) ▲|TMUS187.48+5.32 (+2.92%) ▲|TSLA355.30-0.79 (-0.22%) ▼|TXN252.88-0.46 (-0.18%) ▼|UBER76.57+1.32 (+1.75%) ▲|UNH398.66+2.24 (+0.56%) ▲|UNP289.84-0.74 (-0.25%) ▼|UPS103.58+0.93 (+0.90%) ▲|USB61.78+0.58 (+0.94%) ▲|V376.75+4.01 (+1.07%) ▲|VZ50.43+0.11 (+0.22%) ▲|WFC88.09+1.04 (+1.19%) ▲|WMT105.61-0.31 (-0.29%) ▼|XOM164.01-0.55 (-0.33%) ▼|
21.3 C
New York
Wednesday, September 2, 2026

Tag: patients

newssourceFORcompanyinformationcontent1releasesmarket

Adaptive Biotechnologies Announces Plan to Separate Its MRD and Immune Medicine Businesses

MRD has scaled into a profitable, category-leading MRD diagnostics business, while Immune Medicine has built a differentiated discovery platform powered by proprietary immune data and AI 
MRD has scaled into a profitable, category-leading MRD diagnostics business, while Immune Medicine has built a differentiated discovery platform powered by proprietary immune data and AI

Always Best Care Franchise Owner Expands Senior Care Services into West Jordan

Veteran healthcare leader, Bret Lyman, adds third territory as Utah's senior population continues to growWEST JORDAN, Utah, June 15, 2026 /PRNewswire/ -- Registered nurse and...

Ethyreal Bio Presents First Preclinical Data on ETHY-001 at ENDO 2026, Demonstrating Complete Blockade of Autoantibody Activation of TSHR and Differentiated Activity in TED

– ETHY-001 produced complete blockade of autoantibody-mediated TSHR activation across all patient serum samples tested, demonstrating breadth and consistency of effect –

Lonza Issues Exclusive, Target-Specific License to Antharis Therapeutics to Advance Next-Generation Dual Payload ADCs for Gastrointestinal Cancers

Target-specific licensing agreement enabling Antharis to advance proprietary dual-payload antibody-drug conjugate (ADC) programs using Lonza's site-specific ADC technologiesReinforces Antharis' and Lonza's position at the forefront...

Boston Business Journal names Interra Health to 2026 Best Places to Work List

The Boston Business Journal has named Interra Health to its 2026 Best Places to Work list.

Companion Diagnostics Market worth $11.57 billion by 2031 | MarketsandMarkets™

DELRAY BEACH, Fla., June 15, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the Companion Diagnostics Market is projected to grow from about USD 6.31 billion in...

Cardiawave Announces First Routine Treatments Performed with Valvosoft® Following CE Mark Approval and Accelerates Its Deployment

Cardiawave Announces First Routine Treatments Performed with Valvosoft® Following CE Mark Approval and Accelerates Its Deployment

IntelliGenome Announces Strategic Partnership with CTR Scientific to Advance CRISPR-TB in Mexico

HOUSTON and MONTERREY, Mexico, June 15, 2026 /PRNewswire/ -- IntelliGenome, Inc. today announced a strategic partnership with CTR Scientific (Control Técnico y Representaciones S.A....

DOGECOIN CASH FILES UTILITY PATENT FOR BLOCKCHAIN INFRASTRUCTURE DESIGNED TO SUPPORT DOGECOIN APPLICATION USABILITY

Dogecoin Cash, Inc.(DOGP) files U.S. utility patent for blockchain infrastructure enabling fast Dogecoin confirmations and simplified dApp deployment.

Enterome presents Phase 1/2 iNHL interim data at EHA demonstrating durable OncoMimics™-induced CD8 T cell responses and clinical activity

Enterome presented new interim data from the ongoing Phase 1/2 SIDNEY study of OncoMimics™ EO2463 in patients with indolent non-Hodgkin lymphoma.

Lundbeck presents new Phase II asedebart data in Cushing’s disease at ENDO 2026

Asedebart is an investigational monoclonal antibody designed to neutralize excess adrenocorticotropic hormone (ACTH) and reduce downstream cortisol production in Cushing's disease (CD)Urinary free cortisol...

Lundbeck presents new Phase II asedebart data in Cushing’s disease at ENDO 2026

Asedebart is an investigational monoclonal antibody designed to neutralize excess adrenocorticotropic hormone (ACTH) and reduce downstream cortisol production in Cushing's disease (CD)Urinary free cortisol...

CARsgen Presents Allogeneic CAR T-cell Products CT0596 and CT1190B at EHA 2026

SHANGHAI, June 14, 2026 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces poster...

ENSG Investor News: If You Have Suffered Losses in Ensign Group, Inc. (NASDAQ: ENSG), You Are Encouraged to Contact The Rosen Law Firm About...

NEW YORK, June 14, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of The Ensign Group, Inc. (NASDAQ: ENSG) resulting from allegations that Ensign may have issued materially misleading business information to the investing public.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsPatients

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers